Michelle holds 4 years’ experience, having worked in both established and boutique consultancies since completing her PhD in Clinical and Translational Research at Newcastle University. Michelle originally draws experience from working in the competitive intelligence/market research function, having worked closely with various stakeholders and cross-functional teams, including Market Access teams, to support strategy development and address business questions; she transitioned full-time into working in the Market Access, Pricing and Reimbursement space in 2020. During these 4 years, she has gained extensive experience across a broad number of project types including market opportunity assessments, developing pricing and global market access strategies, value communications and primary payer research; therapy areas include neurology, chronic kidney and liver disease, osteoporosis, addiction disorders and oncology.
